With the city’s children returning to school this week, September is also the month in which you can start to apply for your child’s primary school place. Did you know with a Digital Subscription to ...
Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...
Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback